Determining Clinical Trial Experiences of Lung Cancer Patients
Not yet recruiting
- Conditions
- Lung Cancer
- Registration Number
- NCT05760170
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This trial will admit a wide range of data on the clinical trial experience of lung cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future lung cancer patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient has been diagnosed with lung cancer
- Patient has self-identified as planning to enroll in an observational clinical trial
- Patient is a minimum of 18 years or older
Exclusion Criteria
- Pregnant or nursing patients
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of lung cancer patients who decide to enroll in a clinical trial 3 months Rate of patients who remain in a lung cancer clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method